MetaCap

Sarepta Therapeutics Statistics

NASDAQ: SRPTHealth CareBiotechnology: Pharmaceutical PreparationsUSD

13.33-0.84 (-5.93%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Sarepta Therapeutics by the numbers

Sarepta Therapeutics has a market capitalization of $1.43 billion based on 107.24M shares outstanding. Its trailing P/E ratio is 666.5, above the 3-company peer median of 7.2, and its forward P/E is 8.9. The stock trades 25.5% below its 50-day average and 27.5% below its 200-day average.

Average daily trading volume is 2.70M shares, or about $36.0 million in dollar volume.

Summary generated from market data by MetaCap's automated system. Methodology

SRPT valuation vs. peer median

SRPT compared with the median of 8 peer companies
MetricSRPTPeer medianDifference
Market cap$1.43B$1.40B+2%
Avg. volume2.70M821.59K+229%

Peer median across 8 companies: KLRA, ADRX, DMRA, NRIX, TYRA, ANAB, RAPP, QURE.

Valuation

Price / sales (latest FY)
0.65

Price and trading

Previous close
14.17
Open
13.93
Day range
13.25 – 14.47
52-week range
13.25 – 24.68
52-week change
-24.65%
Beta
—
Volume
2.24M

Dividends and events

Annual dividend
None

Additional statistics

Market Cap
1.43B
Pe
666.50
Forward Pe
8.87
Eps
0.02
Dividend Yield
0.00%
Dividend Rate
0.00
Week52 High
24.68
Week52 Low
13.25
Avg Volume
2.70M
Shares Outstanding
107.24M
Ma50
17.90
Ma200
18.38
Earnings Date
Nov 5, 2026
Pct From52w High
-45.99%
Pct From52w Low
0.60%

Related